BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 32571253)

  • 1. Acute retinal necrosis following dexamethasone intravitreal implant (Ozurdex®) administration in an immunocompetent adult with a history of HSV encephalitis: a case report.
    Zhang ZY; Liu XY; Jiang T
    BMC Ophthalmol; 2020 Jun; 20(1):247. PubMed ID: 32571253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SD-OCT pattern of retinal venous occlusion with cystoid macular edema treated with Ozurdex®.
    Coscas G; Coscas F; Zucchiatti I; Glacet-Bernard A; Soubrane G; Souïed E
    Eur J Ophthalmol; 2011; 21(5):631-6. PubMed ID: 21500185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracrystalline Ozurdex
    Clemente-Tomás R; Hernández-Pérez D; Neira-Ibáñez P; Farías-Rozas F; Torrecillas-Picazo R; Osorio-Alayo V; Duch-Samper AM
    Int Ophthalmol; 2019 Jan; 39(1):207-211. PubMed ID: 29192395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravitreal Dexamethasone Implant versus Intravitreal Ranibizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion in a Chinese Population.
    Gu X; Yu X; Song S; Dai H
    Ophthalmic Res; 2017; 58(1):8-14. PubMed ID: 28334720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of dexamethasone intravitreal implant (Ozurdex) for the treatment of persistent macular edema secondary to retinal vein occlusion in eyes previously treated with anti-vascular endothelial growth factors.
    Tservakis I; Koutsandrea C; Papaconstantinou D; Paraskevopoulos T; Georgalas I
    Curr Drug Saf; 2015; 10(2):145-51. PubMed ID: 25092480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extramacular Retinal Hole Following Intravitreal Dexamethasone Implant: Case Report.
    Ekinci C; Kayıran A; Özdemir H
    Turk J Ophthalmol; 2019 Jun; 49(3):175-177. PubMed ID: 31245982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extension of peripheral nonperfusion in eyes with retinal vein occlusion during intravitreal dexamethasone treatment.
    Rezar-Dreindl S; Eibenberger K; Buehl W; Weigert G; Georgopoulos M; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2018 Jun; 96(4):e455-e459. PubMed ID: 29485235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of morphological and functional changes after repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Bandello F; Parravano M; Cavallero E; Cascavilla ML; Triolo G; Querques L; Borrelli E; Giorno P; Varano M; Lattanzio R; Querques G
    Ophthalmic Res; 2015; 53(4):207-16. PubMed ID: 25896233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
    Bakri SJ; Omar AF
    J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal vein occlusion and the use of a dexamethasone intravitreal implant (Ozurdex®) in its treatment.
    Garweg JG; Zandi S
    Graefes Arch Clin Exp Ophthalmol; 2016 Jul; 254(7):1257-65. PubMed ID: 27178087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion.
    Querques L; Querques G; Lattanzio R; Gigante SR; Del Turco C; Corradetti G; Cascavilla ML; Bandello F
    Ophthalmologica; 2013; 229(1):21-5. PubMed ID: 23006995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
    Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
    Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
    Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
    Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined central retinal vein occlusion and branch retinal artery occlusion treated with intravitreal dexamethasone implant: A case report.
    Arrigo A; Knutsson KA; Rajabjan F; Augustin VA; Bandello F; Parodi MB
    Eur J Ophthalmol; 2021 Mar; 31(2):NP74-NP76. PubMed ID: 32106703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two or more dexamethasone intravitreal implants in treatment-naïve patients with macular edema due to retinal vein occlusion: subgroup analysis of a retrospective chart review study.
    Dugel PU; Capone A; Singer MA; Dreyer RF; Dodwell DG; Roth DB; Shi R; Walt JG; Scott LC; Hollander DA;
    BMC Ophthalmol; 2015 Sep; 15():118. PubMed ID: 26337664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between Ozurdex and intravitreal anti-vascular endothelial growth factor treatment for retinal vein occlusion-related macular edema: A systematic review and meta-analysis of randomized controlled trials.
    Hu Q; Li H; Xu W; Du Y; Ma C; He J
    Indian J Ophthalmol; 2019 Nov; 67(11):1800-1809. PubMed ID: 31638037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.
    Gado AS; Macky TA
    Clin Exp Ophthalmol; 2014; 42(7):650-5. PubMed ID: 24612095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACUTE RETINAL NECROSIS AFTER INTRAVITREAL DEXAMETHASONE IMPLANT. A CASE REPORT.
    Šulavíková Z; Anwarzai J; Krásnik V
    Cesk Slov Oftalmol; 2022; 78(3):144-148. PubMed ID: 35760586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Effect of Age and Initial Central Retinal Thickness on Earlier Need of Repeat Ozurdex Treatment for Macular Edema Due to Retinal Vein Occlusion: A Retrospective Case Series.
    Lin CJ; Chen HS; Su CW; Tien PT; Lin JM; Chen WL; Kuo CY; Lai CT; Tsai YY
    J Ocul Pharmacol Ther; 2017 Dec; 33(10):763-772. PubMed ID: 28949790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.